Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial
収録刊行物
-
- The Lancet Oncology
-
The Lancet Oncology 15 (8), 894-904, 2014-07
Elsevier BV